{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:51:43Z","timestamp":1781679103573,"version":"3.54.5"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Immune checkpoint inhibitor-related pneumonitis (CIP) is a potentially life-threatening adverse event in lung cancer. We report a case of severe probable CIP complicated by acute pulmonary embolism (PE) in a 76-year-old man with stage IIIA lung squamous cell carcinoma after chemoimmunotherapy and thoracic radiotherapy. He developed progressive dyspnea and severe hypoxemia. Serial chest computed tomography (CT) showed bilateral interstitial and ground-glass abnormalities beyond the radiation field, favoring probable CIP, although superimposed infection and obstructive pneumonia could not be fully excluded. During hospitalization, CT pulmonary angiography confirmed acute PE, and lower-extremity ultrasound suggested calf venous thrombosis. The patient required high-flow nasal cannula and received methylprednisolone, tocilizumab, intravenous immunoglobulin, mycophenolate mofetil, antimicrobial therapy, and therapeutic anticoagulation. Despite partial clinical improvement, serial chest CT demonstrated continued radiographic progression. This case highlights the need for dynamic differential diagnosis, multidisciplinary management, and close bedside monitoring in complex post-radiotherapy CIP.<\/jats:p>","DOI":"10.3389\/fmed.2026.1860616","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:52:42Z","timestamp":1781675562000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Severe probable immune checkpoint inhibitor-related pneumonitis after thoracic radiotherapy complicated by acute pulmonary embolism in lung squamous cell carcinoma: a case report"],"prefix":"10.3389","volume":"13","author":[{"given":"Fangping","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Radiotherapy, Jinhua Municipal Central Hospital","place":["Jinhua, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanli","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Jinhua Municipal Central Hospital","place":["Jinhua, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Jinhua Municipal Central Hospital","place":["Jinhua, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongling","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Jinhua Municipal Central Hospital","place":["Jinhua, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingshan","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Jinhua Municipal Central Hospital","place":["Jinhua, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqing","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Jinhua Municipal Central Hospital","place":["Jinhua, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1191681","DOI":"10.3389\/fonc.2023.1191681","article-title":"PD-1\/PD-L1 inhibitor treatment and its impact on clinical imaging in non-small cell lung cancer: a systematic review and meta-analysis of immune-related adverse events","volume":"13","author":"Mohammed","year":"2023","journal-title":"Front Oncol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1159\/000526141","article-title":"Risk factors for immune checkpoint inhibitor-related pneumonitis in Cancer patients: a systemic review and Meta-analysis","volume":"101","author":"Zhou","year":"2022","journal-title":"Respiration"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"108011","DOI":"10.1016\/j.intimp.2021.108011","article-title":"The association between the incidence risk of pneumonitis and PD-1\/PD-L1 inhibitors in advanced NSCLC: a meta-analysis of randomized controlled trials","volume":"99","author":"Lin","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"108353","DOI":"10.1016\/j.intimp.2021.108353","article-title":"Adverse events of immunotherapy in non-small cell lung cancer: a systematic review and network meta-analysis","volume":"102","author":"Zhou","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/mp.15451","article-title":"Differentiation between immune checkpoint inhibitor-related and radiation pneumonitis in lung cancer by CT radiomics and machine learning","volume":"49","author":"Cheng","year":"2022","journal-title":"Med Phys"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"111489","DOI":"10.1016\/j.intimp.2024.111489","article-title":"Distinguishing immune checkpoint inhibitor-related pneumonitis from radiation pneumonitis by CT radiomics features in non-small cell lung cancer","volume":"128","author":"Peiliang Wang","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1111\/1759-7714.14693","article-title":"Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor","volume":"13","author":"Wang","year":"2022","journal-title":"Thorac Cancer"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of Immune-Related Adverse Events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update","volume":"39","author":"Schneider","year":"2021","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1111\/1759-7714.13187","article-title":"High mortality and poor treatment efficacy of immune checkpoint inhibitors in patients with severe grade checkpoint inhibitor pneumonitis in non-small cell lung cancer","volume":"10","author":"Tone","year":"2019","journal-title":"Thorac Cancer"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"663986","DOI":"10.3389\/fimmu.2021.663986","article-title":"Immune checkpoint inhibitor-associated pneumonitis in non-small cell lung Cancer: current understanding in characteristics, diagnosis, and management","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1656063","DOI":"10.3389\/fimmu.2025.1656063","article-title":"Advances in the mechanisms, imaging characteristics and management strategies for immune checkpoint inhibitor-related pneumonitis","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e1822","DOI":"10.1002\/onco.13900","article-title":"Radiation versus immune checkpoint inhibitor associated pneumonitis: distinct radiologic morphologies","volume":"26","author":"Chen","year":"2021","journal-title":"Oncologist"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1454114","DOI":"10.3389\/fimmu.2024.1454114","article-title":"Clinical characteristics and biomarkers of severe immune checkpoint inhibitor-related pneumonitis triggered by immunotherapy followed by radiation: a case report","volume":"15","author":"Zhu","year":"2024","journal-title":"Front Immunol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.4103\/jcrt.JCRT_971_20","article-title":"Immune-related organizing pneumonitis in non-small cell lung cancer receiving PD-1 inhibitor treatment: a case report and literature review","volume":"16","author":"Yin","year":"2020","journal-title":"J Cancer Res Ther"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/cas.15621","article-title":"Nivolumab-induced radiation recall pneumonitis in non-small-cell lung cancer patients with thoracic radiation therapy","volume":"114","author":"Noda-Narita","year":"2023","journal-title":"Cancer Sci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.3390\/curroncol30030230","article-title":"Immune Checkpoint Inhibitors-Associated Thrombosis: Incidence, Risk Factors and Management","volume":"30","author":"Wang","year":"2023","journal-title":"Curr Oncol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e002252","DOI":"10.1136\/jitc-2020-002252","article-title":"Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis","volume":"9","author":"Gatti-Mays","year":"2021","journal-title":"J Immunother Cancer"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2147\/CPAA.S534323","article-title":"Recurrent checkpoint inhibitor-related pneumonitis refractory to corticosteroid treatment: a case report and literature review","volume":"17","author":"Yu","year":"2025","journal-title":"Clin Pharmacol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pccm.2024.12.001","article-title":"Clinical management of checkpoint inhibitor pneumonitis: focus, challenges, and future directions","volume":"3","author":"Xu","year":"2025","journal-title":"Chin Med J Pulm Crit Care Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1188\/16.CJON.319-326","article-title":"Programmed Death-1 inhibition in Cancer with a focus on non-small cell lung Cancer: rationale, nursing implications, and patient management strategies","volume":"20","author":"Lewis","year":"2016","journal-title":"Clin J Oncol Nurs"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2506302","DOI":"10.1080\/21645515.2025.2506302","article-title":"The role of nursing in enhancing quality of life for lung cancer patients receiving targeted and immunotherapy: challenges, opportunities, and future directions","volume":"21","author":"Sun","year":"2025","journal-title":"Hum Vaccin Immunother"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1860616\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:52:43Z","timestamp":1781675563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1860616\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":21,"alternative-id":["10.3389\/fmed.2026.1860616"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1860616","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"article-number":"1860616"}}